Engineering novel biosensors for unmet needs

Human Healthcare

Helping couples grow a family by allowing women to assess their fertility health

Animal Healthcare

Providing farmers a tool to manage their herd and time animal reproduction

Environmental Wellness

Evaluating the health of our environment to revitalize fragile ecosystems

Founding Team

Uroš Kuzmanović

CEO

Genomics, SynBio, & Sensors

Roman Addokhi

Senior Scientist

Sensors & Devices

James Galagan, PhD

President

Genomics, Sensors, & Devices

Mark Grinstaff, PhD

Board Member

Sensors & Chemistry

Douglas Densmore, PhD

Board Member

Automation & SynBio

Catherine Klapperich, PhD

Founding Partner

Diagnostics & Devices

Karen Allen, PhD

Founding Partner

Protein Engineering

News

  • 9/20/21

BioSens8 is participating as a host company in the Boston University Questrom business school class, Bench to Bedside, to discover potential markets our platform technology can be applied toward and then follow with customer discovery!

  • 9/14/21

BioSens8 is participating as a host company in the MIT Sloan business school class, E-Lab, to diver deeper into unmet needs and identify the value propositions of our progesterone biosensor in the FemTech space!

  • 7/20/21

NSF has awarded our STTR Phase I proposal for developing a novel progesterone biosensor for monitoring fertility health! We're delighted to have the support of NSF, the funds will be used for achieving technical milestones required for commercialization.

  • 6/28/21

BioSens8 was selected from more than 3000 global applicants to join the MassChallenge 2021 cohort! We're excited to partake alongside 228 other startups!

  • 5/3/2021

Boston University has awarded Dr. James Galagan with the Ignition Award! The funds will be used for R&D work toward bringing a novel animal healthcare biosensor to market.

  • 4/7/2021

BioSens8 was awarded the second largest prize at the M2D2 $200K Challenge! We're thrilled to be supported by M2D2 with a cash award! Check out our award winning pitch.

  • 4/7/2021

BioSens8 pitched in front of a panel of Med Tech judges including industry leaders, investors, and practitioners for the BU Ignition Award.

  • 3/8/2021

BioSens8 was selected as a M2D2 $200K Finalist! We were one of 15 startups (out of more than 170 worldwide entrants) in the running for $200,000 in in-kind services and research support from sponsors that include UMass Lowell, Amgen, Boston Scientific, Johnson & Johnson Innovation, Massachusetts Life Sciences Center, Mintz, and others.

The virtual M2D2 $200K Challenge Finalist Pitch-off being hosted through Zoom on Wednesday, March 24th. Register for free and watch us pitch here!

  • 3/4/2021

BioSens8 successfully submitted a NSF STTR Phase I application.

  • 2/11/2021

BioSens8 was selected as an Ignition Award finalist! Our full proposal was well received by the Ignition Review Committee, made up of outside representatives (investors, industry) and BU academics. As a finalist, BioSens8 will present for the Ignition Award on 4/7/2021.

  • 12/16/2020

BioSens8 officially incorporated.

  • 11/23/2020

BioSens8 was selected to submit a full proposal for the Boston University Ignition Award! The Ignition Award program is designed to help Boston University researchers bring their projects with commercial potential to the next level.

Contact

If you wish to invest, become a business partner, license our technology or require a biosensor solution

please contact: uros@biosens8.com